IN2013MU01111A - - Google Patents

Info

Publication number
IN2013MU01111A
IN2013MU01111A IN1111MU2013A IN2013MU01111A IN 2013MU01111 A IN2013MU01111 A IN 2013MU01111A IN 1111MU2013 A IN1111MU2013 A IN 1111MU2013A IN 2013MU01111 A IN2013MU01111 A IN 2013MU01111A
Authority
IN
India
Prior art keywords
ticagrelor
preparation
pharmaceutically acceptable
relates
acceptable salts
Prior art date
Application number
Other languages
English (en)
Inventor
G Bhatt Navin
Naik Samir
Kumar Sharma Ajay
Choraghe Mahendra
Bhaskar Bhirud Shekhar
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Priority to PCT/IN2014/000165 priority Critical patent/WO2014155389A2/en
Priority to IN1111MU2013 priority patent/IN2013MU01111A/en
Publication of IN2013MU01111A publication Critical patent/IN2013MU01111A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
IN1111MU2013 2013-03-25 2014-03-14 IN2013MU01111A (ar)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000165 WO2014155389A2 (en) 2013-03-25 2014-03-14 Process for preparation of ticagrelor
IN1111MU2013 IN2013MU01111A (ar) 2013-03-25 2014-03-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1111MU2013 IN2013MU01111A (ar) 2013-03-25 2014-03-14

Publications (1)

Publication Number Publication Date
IN2013MU01111A true IN2013MU01111A (ar) 2015-05-01

Family

ID=51625566

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1111MU2013 IN2013MU01111A (ar) 2013-03-25 2014-03-14

Country Status (2)

Country Link
IN (1) IN2013MU01111A (ar)
WO (1) WO2014155389A2 (ar)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801583A (zh) * 2014-12-31 2016-07-27 徐州万邦金桥制药有限公司 一种替格瑞洛的纯化方法
CN109633063B (zh) * 2018-12-26 2021-05-04 哈尔滨医科大学 一种人血浆中替格瑞洛及其活性代谢产物浓度的检测方法
CN112394109A (zh) * 2019-08-12 2021-02-23 武汉武药科技有限公司 替格瑞洛中杂质的检测方法
CN110642862B (zh) * 2019-10-29 2021-01-26 株洲千金药业股份有限公司 一种替格瑞洛乙酯化杂质的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
WO2012138981A2 (en) * 2011-04-06 2012-10-11 Teva Pharmaceutical Industries Ltd. New intermediates and processes for preparing ticagrelor
CN102731467B (zh) * 2011-04-15 2015-12-16 博瑞生物医药(苏州)股份有限公司 替卡格雷的中间体及制备替卡格雷的方法
CN102603751A (zh) * 2012-02-24 2012-07-25 中国药科大学 ***并(4,5-d)嘧啶衍生物及其制备方法与在制药中的用途
CN102875537A (zh) * 2012-09-10 2013-01-16 常州制药厂有限公司 一种新的抗血栓药物的制备方法

Also Published As

Publication number Publication date
WO2014155389A3 (en) 2015-01-15
WO2014155389A2 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
HUS2100006I1 (hu) Avapritinib és gyógyászatilag elfogadható sói
IN2014CH00247A (ar)
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2013MU00646A (ar)
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
IN2013MU03641A (ar)
IL245474A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
EP3014628B8 (en) Process of generating germanium-68
IL245649A0 (en) A process for the preparation of ragdanosone
IL245476B (en) Process for the preparation of 5-fluoro-1h-pyrazoles
IN2013MU03070A (ar)
RS56756B1 (sr) Postupak za pripremanje ksantohumola
IN2013MU01111A (ar)
IN2013MU01113A (ar)
IL229326A (en) Process for making n-iodine-affluent
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
IN2013CH04314A (ar)
IN2013MU02528A (ar)
MX2017007510A (es) Un proceso para la fabricacion de idalopirdina.
IN2014CH01391A (ar)
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
WO2014147464A3 (en) Novel process for the preparation of tolcapone
IN2013MU03768A (ar)
EP3049402A4 (en) Process for preparation of alogliptin